Drug-induced rheumatic syndromes. Diagnosis, clinical features and management

Medical Toxicology and Adverse Drug Experience
M G Cohen, M V Prowse

Abstract

In order to avoid inappropriate therapy and prolonged morbidity, it is important to recognise when a patient's rheumatic complaints are due to drugs. However, this is often difficult because of the large number of drugs that have been implicated and the diversity of clinical presentations. Arthropathy may be seen with several different syndromes, including drug-induced lupus erythematosus (DILE), serum sickness and gout. The most widely reported of these is DILE, which usually develops after some months or even years of drug therapy. While many authors do not specifically require their presence for the diagnosis of DILE, antinuclear antibodies have been detected in the great majority of reported patients with DILE, whatever the causative drug. In contrast, patients who develop arthropathy soon after commencing a drug rarely have antinuclear antibodies and appear to be distinct from patients with DILE. Apart from arthropathy, a number of other syndromes that appear to have an immunological basis may be induced by drugs. Cutaneous vasculitis is not uncommon and drugs are frequently considered to be the aetiological factor. Whether drugs may cause larger vessel systemic vasculitis is less certain. Rarely, polymyositis and sclerode...Continue Reading

References

Aug 1, 1975·Seminars in Arthritis and Rheumatism·S L Lee, P H CHase
Dec 20, 1979·The New England Journal of Medicine·R LahitaM M Reidenberg
Dec 1, 1977·Annals of Internal Medicine·M R KhairiC C Johnston
May 1, 1979·Human Pathology·F G MullickJ J Fenoglio
Mar 6, 1975·The New England Journal of Medicine·C W Parker
Jan 1, 1989·Medical Toxicology and Adverse Drug Experience·F S MonteagudoP I Folb
Jan 1, 1987·American Journal of Nephrology·A Martinez-VeaC Richart
Aug 1, 1988·Arthritis and Rheumatism·P N SambrookN A Pocock
Jul 1, 1985·Journal of the American Academy of Dermatology·G P PavlidakeyS Daneshvar
Jun 18, 1987·The New England Journal of Medicine·R W KunclM Peper
Feb 1, 1988·Baillière's Clinical Endocrinology and Metabolism·J A Eisman
Aug 23, 1986·British Medical Journal·L KlapholzL Weinrauch
Mar 1, 1988·Annals of Internal Medicine·M G CohenM J Ahern
Jun 2, 1988·The New England Journal of Medicine·M C TotoritisR L Rubin
Nov 1, 1987·Seminars in Arthritis and Rheumatism·L P EndoR S Panush
Nov 1, 1987·Seminars in Arthritis and Rheumatism·K M Lohr
Sep 1, 1986·Annals of Internal Medicine·M NavarroP Huguet
Mar 1, 1986·Annals of Internal Medicine·R H WeisbartR J Boucek
Feb 1, 1986·Seminars in Arthritis and Rheumatism·P RushM Kapusta
Jul 1, 1987·Arthritis and Rheumatism·P N SambrookS Eberl
May 1, 1986·British Journal of Rheumatology·A InnesG R Cato
Jun 1, 1986·The British Journal of Radiology·T GoodfellowJ Bamforth
Oct 1, 1986·Arthritis and Rheumatism·T M ZizicM B Stevens
Nov 1, 1986·Annals of the Rheumatic Diseases·P N SambrookG D Champion
Jul 1, 1985·Annals of Internal Medicine·B R ReedD A Norris
Jul 1, 1985·Clinical Immunology and Immunopathology·R L RubinE M Tan
Feb 1, 1985·Arthritis and Rheumatism·A Epstein, P Barland
Jul 1, 1985·The American Journal of the Medical Sciences·J J Cush, E A Goldings
Dec 1, 1985·Calcified Tissue International·C Gennari, B Imbimbo
Feb 1, 1986·Seminars in Arthritis and Rheumatism·A Alonso-RuizJ Beltrán-Gutiérrez
Mar 1, 1985·Annals of Internal Medicine·P AmadioL Dashow
May 1, 1985·British Journal of Rheumatology·D G Macfarlane, P A Dieppe
Aug 1, 1985·Seminars in Arthritis and Rheumatism·G D McCormack, W F Barth
Oct 1, 1965·Arthritis and Rheumatism·F E Demartini

❮ Previous
Next ❯

Citations

Dec 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Bernard Bannwarth
Jan 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C BallewC Gillespie
Sep 1, 2004·Modern Rheumatology·Aliye Kapukıran TosunGülçin Kaymak Karataş
Apr 1, 1991·Baillière's Clinical Rheumatology·J J DubostB Sauvezie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Actas dermo-sifiliográficas
M PretelA España
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
P VergneR Trèves
Archives of Dermatological Research
Camilla Dalle VedoveGiampiero Girolomoni
© 2022 Meta ULC. All rights reserved